Uber appoints new UK chief as renewal of London licence looms
Melinda Roylett joins the firm having previously headed the European operation of digital payment firm Square
Company
Pan-Biome Pharmaceuticals Inc.
PRIVATE:[TICKER]
Pan-Biome Pharmaceuticals Inc is a preclinical biopharmaceutical company with a suite of natural product-based compounds dedicated to healthy aging and advancing drugs that can treat and potentially slow the onset of many age-related diseases. Its compounds are well tolerated and exhibit novel anti-inflammatory, antimicrobial, antioxidant, and anti-cancer properties. In July 2020, the private company was spun out from Derm-Biome Pharmaceuticals Inc, a Vancouver-based pre-clinical biopharma company focused on skin diseases and healthy ageing.
223 stories · page 12 of 12
Uber posts massive 2Q loss, revenue falls short of expectations as core ride-hailing growth slows
The NYSE-listed firm reported a net loss of $5.2 billion, up from a deficit of $878 million a year earlier, reflecting $3.9 billion of stock-based compensation expenses related to its IPO earlier this year,
Talks to take Nordstrom private could unravel
Lenders are anxious about the retail industry, given dwindling mall traffic and the surprise bankruptcy filing of Toys ‘R’ Us last month